SCHEMBL14901147

SCHEMBL14901147

CCCCCCCCOc1ccc(/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1OCC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.74
KMT2A Q03164 2/20 0.67
APAF1 O14727 1/20 0.67
ADAMTS5 Q9UNA0 1/20 0.67
MAPT P10636 3/20 0.66
NCOA3 Q9Y6Q9 2/20 0.66
MITF O75030 1/20 0.66
RAB9A P51151 1/20 0.66
CTNNB1 P35222 2/20 0.62
TCF4 P15884 1/20 0.62
DVL1 O14640 1/20 0.62
PSMD14 O00487 1/20 0.62
POLB P06746 1/20 0.62
PLEC Q15149 1/20 0.62
KLKB1 P03952 1/20 0.61
AKR1B1 P15121 6/20 0.58
TAS2R14 Q9NYV8 1/20 0.58
ALDH1A1 P00352 1/20 0.57
PTPN2 P17706 2/20 0.56
PTPN1 P18031 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008625 0.96 CTNNB1 (0.69) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008627 0.94 APAF1 (0.66) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008528 0.94 FABP4 (0.78) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008497 0.93 CTNNB1 (0.73) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008421 0.93 CTNNB1 (0.73) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008549 0.93 FABP4 (0.85) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008416 0.92 CTNNB1 (0.75) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL13446874 0.91 FABP4 (0.60) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008418 0.89 CTNNB1 (0.76) FABP4KMT2AAPAF1ADAMTS5MAPT
SCHEMBL12008511 0.89 CTNNB1 (0.78) FABP4KMT2AAPAF1ADAMTS5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 FABP4 1744/4885KMT2A 4591/4885APAF1 2916/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 FABP4 1744/4885KMT2A 4591/4885APAF1 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.